Back to top
more

Ardelyx (ARDX)

(Delayed Data from NSDQ)

$6.48 USD

6.48
5,608,327

+0.04 (0.62%)

Updated Apr 19, 2024 04:00 PM ET

After-Market: $6.50 +0.02 (0.31%) 6:16 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 250)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ARDX

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Ardelyx, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 184 124 117 186 248
Receivables 22 8 1 0 1
Notes Receivable 0 0 0 0 0
Inventories 12 3 0 0 0
Other Current Assets 27 19 16 8 4
Total Current Assets 246 154 134 195 252
Net Property & Equipment 1 1 2 2 3
Investments & Advances 0 0 0 2 0
Other Non-Current Assets 37 25 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 0 0 0 0 0
Deposits & Other Assets 8 1 1 1 0
Total Assets 298 190 150 202 260
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 11 11 4 6 2
Current Portion Long-Term Debt 0 27 32 4 1
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 13 8 5 6 4
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 22 17 7 11 12
Total Current Liabilities 50 66 53 28 22
Mortgages 0 0 0 0 0
Deferred Taxes/Income 9 9 5 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 50 0 0 47 49
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 20 11 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 131 92 67 75 73
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 1,013 879 796 681 647
Retained Earnings -846 -780 -713 -555 -460
Other Equity 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 167 98 83 126 187
Total Liabilities & Shareholder's Equity 298 190 150 202 260
Total Common Equity 167 98 83 126 187
Shares Outstanding 232.10 198.50 112.70 90.20 88.70
Book Value Per Share 0.72 0.50 0.73 1.40 2.10

Fiscal Year End for Ardelyx, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 184 165 128 130
Receivables NA 22 43 9 12
Notes Receivable NA 0 0 0 0
Inventories NA 12 9 8 5
Other Current Assets NA 27 24 18 20
Total Current Assets NA 246 241 162 167
Net Property & Equipment NA 1 1 1 1
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 37 39 40 40
Deferred Charges NA 0 0 0 0
Intangibles NA 0 0 0 0
Deposits & Other Assets NA 8 2 1 1
Total Assets NA 298 289 211 217
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 11 8 5 11
Current Portion Long-Term Debt NA 0 0 27 27
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 13 8 7 5
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 22 23 18 17
Total Current Liabilities NA 50 44 62 63
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 9 10 9 12
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 50 27 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 14 13 12
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 131 98 88 92
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 1,013 1,009 947 932
Retained Earnings NA -846 -817 -824 -807
Other Equity NA 0 0 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 167 191 123 125
Total Liabilities & Shareholder's Equity NA 298 289 211 217
Total Common Equity 0 167 191 123 125
Shares Outstanding 232.60 232.10 232.10 217.80 214.40
Book Value Per Share 0.00 0.72 0.82 0.57 0.58